KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Receivables (2016 - 2025)

Nu Skin Enterprises' Receivables history spans 17 years, with the latest figure at $39.5 million for Q4 2025.

  • For Q4 2025, Receivables fell 22.13% year-over-year to $39.5 million; the TTM value through Dec 2025 reached $39.5 million, down 22.13%, while the annual FY2025 figure was $39.5 million, 22.13% down from the prior year.
  • Receivables for Q4 2025 was $39.5 million at Nu Skin Enterprises, down from $48.9 million in the prior quarter.
  • Across five years, Receivables topped out at $77.3 million in Q3 2023 and bottomed at $39.5 million in Q4 2025.
  • The 5-year median for Receivables is $57.6 million (2023), against an average of $56.8 million.
  • The largest annual shift saw Receivables tumbled 34.83% in 2021 before it skyrocketed 60.97% in 2023.
  • A 5-year view of Receivables shows it stood at $41.3 million in 2021, then grew by 14.68% to $47.4 million in 2022, then grew by 23.93% to $58.7 million in 2023, then fell by 13.48% to $50.8 million in 2024, then dropped by 22.13% to $39.5 million in 2025.
  • Per Business Quant, the three most recent readings for NUS's Receivables are $39.5 million (Q4 2025), $48.9 million (Q3 2025), and $59.7 million (Q2 2025).